Bayer U.S. LLC is the American arm of Bayer, a large pharmaceutical and life sciences company. Its filings show it lobbies on health, pharmacy, and agriculture issues, tracking federal policy that could affect the pharmaceutical and healthcare industries and Bayer’s businesses. It has reported hiring HB Strategies and disclosed $480,000 across four filings through January 19, 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ERIC LAUSTEN
The latest disclosures for this client.
HB STRATEGIES
Q1HB STRATEGIES
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
HB STRATEGIES
GREGG HARTLEY
HB STRATEGIES
CHRISTIAN MORGAN
HB STRATEGIES
HB STRATEGIES
Q3HB STRATEGIES
Q2HB STRATEGIES
Q1